250 related articles for article (PubMed ID: 28278205)
21. Carboxypeptidase B2 deficiency reveals opposite effects of complement C3a and C5a in a murine polymicrobial sepsis model.
Shao Z; Nishimura T; Leung LL; Morser J
J Thromb Haemost; 2015 Jun; 13(6):1090-102. PubMed ID: 25851247
[TBL] [Abstract][Full Text] [Related]
22. [Changes of anaphylatoxin C5a in chronic obstructive pulmonary disease and the relationship with systemic and local inflammation].
Zhang J; Yao WZ; Sun YC
Zhonghua Jie He He Hu Xi Za Zhi; 2008 May; 31(5):356-9. PubMed ID: 18953960
[TBL] [Abstract][Full Text] [Related]
23. Expression of soluble triggering receptor expressed on myeloid cells-1 in childhood CF and non-CF bronchiectasis.
Masekela R; Anderson R; de Boeck K; Vreys M; Steel HC; Olurunju S; Green RJ
Pediatr Pulmonol; 2015 Apr; 50(4):333-9. PubMed ID: 25348906
[TBL] [Abstract][Full Text] [Related]
24. Induced sputum matrix metalloproteinase-9 correlates with lung function and airway inflammation in children with cystic fibrosis.
Sagel SD; Kapsner RK; Osberg I
Pediatr Pulmonol; 2005 Mar; 39(3):224-32. PubMed ID: 15635615
[TBL] [Abstract][Full Text] [Related]
25. Resistin is elevated in cystic fibrosis sputum and correlates negatively with lung function.
Forrest OA; Chopyk DM; Gernez Y; Brown MR; Conrad CK; Moss RB; Tangpricha V; Peng L; Tirouvanziam R
J Cyst Fibros; 2019 Jan; 18(1):64-70. PubMed ID: 29937317
[TBL] [Abstract][Full Text] [Related]
26. Association of airway cathepsin B and S with inflammation in cystic fibrosis.
Martin SL; Moffitt KL; McDowell A; Greenan C; Bright-Thomas RJ; Jones AM; Webb AK; Elborn JS
Pediatr Pulmonol; 2010 Sep; 45(9):860-8. PubMed ID: 20632407
[TBL] [Abstract][Full Text] [Related]
27. Changes in airway inflammation during pulmonary exacerbations in patients with cystic fibrosis and primary ciliary dyskinesia.
Ratjen F; Waters V; Klingel M; McDonald N; Dell S; Leahy TR; Yau Y; Grasemann H
Eur Respir J; 2016 Mar; 47(3):829-36. PubMed ID: 26585432
[TBL] [Abstract][Full Text] [Related]
28. Impact of Pseudomonas and Staphylococcus infection on inflammation and clinical status in young children with cystic fibrosis.
Sagel SD; Gibson RL; Emerson J; McNamara S; Burns JL; Wagener JS; Ramsey BW; ;
J Pediatr; 2009 Feb; 154(2):183-8. PubMed ID: 18822427
[TBL] [Abstract][Full Text] [Related]
29. Neutrophil collagenase in sputum from patients with cystic fibrosis.
Power C; O'Connor CM; MacFarlane D; O'Mahoney S; Gaffney K; Hayes J; FitzGerald MX
Am J Respir Crit Care Med; 1994 Sep; 150(3):818-22. PubMed ID: 8087357
[TBL] [Abstract][Full Text] [Related]
30. Anti-protease levels in cystic fibrosis are associated with lung function, recovery from pulmonary exacerbations and may be gender-related.
Essilfie AT; Houston N; Maniam P; Hartel G; Okano S; Reid DW
Respirology; 2023 Jun; 28(6):533-542. PubMed ID: 36642534
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics and tolerability of oral sildenafil in adults with cystic fibrosis lung disease.
Taylor-Cousar JL; Wiley C; Felton LA; St Clair C; Jones M; Curran-Everett D; Poch K; Nichols DP; Solomon GM; Saavedra MT; Accurso FJ; Nick JA
J Cyst Fibros; 2015 Mar; 14(2):228-36. PubMed ID: 25466700
[TBL] [Abstract][Full Text] [Related]
32. Analysis of inflammatory and immune response biomarkers in sputum and exhaled breath condensate by a multi-parametric biochip array in cystic fibrosis.
Colombo C; Faelli N; Tirelli AS; Fortunato F; Biffi A; Claut L; Cariani L; Daccò V; Prato R; Conese M
Int J Immunopathol Pharmacol; 2011; 24(2):423-32. PubMed ID: 21658316
[TBL] [Abstract][Full Text] [Related]
33. Activated complement in the sputum from patients with cystic fibrosis.
Schiøtz PO; Sørensen H; Høiby M
Acta Pathol Microbiol Scand C; 1979 Feb; 87C(1):1-5. PubMed ID: 433601
[TBL] [Abstract][Full Text] [Related]
34. Alterations in systemic complement component 3a and 5a levels in patients with cerebral arteriovenous malformations.
Haque R; Hwang BY; Appelboom G; Piazza MA; Guo K; Connolly ES
J Clin Neurosci; 2011 Sep; 18(9):1235-9. PubMed ID: 21742500
[TBL] [Abstract][Full Text] [Related]
35. Perioperative effect of methylprednisolone given during lung surgery on plasma concentrations of C3a and C5a.
Mikawa K; Ikegaki J; Maekawa N; Hoshina H; Tanaka O; Goto R; Obara H; Kusunoki M
Scand J Thorac Cardiovasc Surg; 1990; 24(3):229-33. PubMed ID: 2293363
[TBL] [Abstract][Full Text] [Related]
36. Biocompatibility of hemodialysis membranes: interrelations between plasma complement and cytokine levels.
Varela MP; Kimmel PL; Phillips TM; Mishkin GJ; Lew SQ; Bosch JP
Blood Purif; 2001; 19(4):370-9. PubMed ID: 11574733
[TBL] [Abstract][Full Text] [Related]
37. A specialized method of sputum collection and processing for therapeutic interventions in cystic fibrosis.
McElvaney OJ; Gunaratnam C; Reeves EP; McElvaney NG
J Cyst Fibros; 2019 Mar; 18(2):203-211. PubMed ID: 29960875
[TBL] [Abstract][Full Text] [Related]
38. Relationship between airway dysbiosis, inflammation and lung function in adults with cystic fibrosis.
Frey DL; Boutin S; Dittrich SA; Graeber SY; Stahl M; Wege S; Herth FJF; Sommerburg O; Schultz C; Mall MA; Dalpke AH
J Cyst Fibros; 2021 Sep; 20(5):754-760. PubMed ID: 33431308
[TBL] [Abstract][Full Text] [Related]
39. The role of anaphylatoxins C3a and C5a in regulating innate and adaptive immune responses.
Peng Q; Li K; Sacks SH; Zhou W
Inflamm Allergy Drug Targets; 2009 Jul; 8(3):236-46. PubMed ID: 19601884
[TBL] [Abstract][Full Text] [Related]
40. [Immunologic monitoring of patients with cystic fibrosis: value of different laboratory findings].
Pevnitskiĭ LA; Pukhal'skiĭ AL; Kapranov NI; Kalashnikova EA; Shmarina GV; Pukhal'skaia DA; Kokarovtseva SN; Kashirskaia NIu; Shabalova LA
Vestn Ross Akad Med Nauk; 2000; (5):40-6. PubMed ID: 10881662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
